Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women()

BACKGROUND: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. METHODS: Efficacy, immunogenicity, and safety outcomes were assessed in Latin American participants enrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Sternberg, Ángela María, Moreira, Edson D., Restrepo, Jaime A., Lazcano-Ponce, Eduardo, Cabello, Robinson, Silva, Arnaldo, Andrade, Rosires, Revollo, Francisco, Uscanga, Santos, Victoria, Alejandro, Guevara, Ana María, Luna, Joaquín, Plata, Manuel, Dominguez, Claudia Nossa, Fedrizzi, Edison, Suarez, Eugenio, Reina, Julio C., Ellison, Misoo C., Moeller, Erin, Ritter, Michael, Shields, Christine, Cashat, Miguel, Perez, Gonzalo, Luxembourg, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887018/
https://www.ncbi.nlm.nih.gov/pubmed/29269325
http://dx.doi.org/10.1016/j.pvr.2017.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887018/
https://www.ncbi.nlm.nih.gov/pubmed/29269325
http://dx.doi.org/10.1016/j.pvr.2017.12.004

Ejemplares similares